A Combined YopB and LcrV Subunit Vaccine Elicits Protective Immunity against Yersinia Infection in Adult and Infant Mice

The Journal of Immunology : Official Journal of the American Association of Immunologists
Shannon J HeineM F Pasetti

Abstract

Yersinia enterocolitica causes a severe enteric infection in infants and young children. There is no vaccine approved for use in humans. We investigated the immunogenicity and protective capacity of Yersinia YopB, a conserved type III secretion system protein, alone or combined with LcrV in adult mice immunized intranasally. YopB or LcrV (5 μg) administered with the Escherichia coli double mutant heat-labile toxin (dmLT) adjuvant afforded modest (10-30%) protection against lethal Y. enterocolitica oral infection. The combination of YopB and LcrV (5 μg each) dramatically improved vaccine efficacy (70-80%). Additionally, it afforded complete protection against Y. pestis pulmonary infection. Immunization with YopB/LcrV+dmLT resulted in Ag-specific serum IgG, systemic and mucosal Ab-secreting cells, as well as IFN-γ, TNF-α, IL-2, IL-6, IL-17A, and KC production by spleen cells. Serum Abs elicited by YopB/LcrV+dmLT had enhanced bactericidal and opsonophagocytic killing activity. After Y. enterocolitica challenge, YopB/LcrV+dmLT-vaccinated mice exhibited intact intestinal tissue, active germinal centers in mesenteric lymph nodes, IgG+ and IgA+ plasmablasts in the lamina propria, and Abs in intestinal fluid. On the contrary, complete ...Continue Reading

References

Apr 1, 1985·Infection and Immunity·I BölinH Wolf-Watz
Jun 1, 1985·Infection and Immunity·G MazzaD T Kingsbury
Apr 1, 1993·Zentralblatt Für Bakteriologie : International Journal of Medical Microbiology·I B AutenriethJ Heesemann
Mar 1, 1997·Infection and Immunity·J Nemeth, S C Straley
Aug 26, 1998·FEMS Microbiology Letters·N DorrellB W Wren
Sep 16, 1998·Clinical and Experimental Immunology·V A KempfI B Autenrieth
Mar 25, 1999·Microbial Pathogenesis·A SchmidtH U Beuscher
Dec 22, 1999·Microbes and Infection·E J Bottone
Apr 9, 2001·Infection and Immunity·R Nordfelth, H Wolf-Watz
May 12, 2001·Vaccine·C A Siegrist
Jun 6, 2003·Best Practice & Research. Clinical Rheumatology·J S Hill Gaston, Mark S Lillicrap
Aug 19, 2007·Molecular Microbiology·Petr BrozGuy R Cornelis
Jun 25, 2010·Journal of Pharmaceutical Sciences·Luis A Brito, Manmohan Singh
Dec 22, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jr-Shiuan LinStephen T Smiley
Dec 29, 2011·Infection and Immunity·Francisco J Martinez-BecerraWendy L Picking
Jan 1, 2011·Journal of Pathogens·Atiqur RahmanChiraporn Ananchaipattana
Jun 23, 2012·American Journal of Respiratory and Critical Care Medicine·Weihui WuGregory P Priebe
Jul 11, 2012·The Journal of Experimental Medicine·R William DePaoloBana Jabri
Dec 1, 2012·Comparative Immunology, Microbiology and Infectious Diseases·Gabriela Mellado-SanchezMarcela F Pasetti
Sep 5, 2013·Infection and Immunity·Nikki J WagnerVirginia L Miller
Jan 24, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Shannon J HeineMarcela F Pasetti
Jul 3, 2015·PLoS Pathogens·Anjelique Schulfer, Martin J Blaser
Mar 17, 2016·Vaccine·Sachin ManiRichard I Walker
Jul 15, 2016·Clinical and Vaccine Immunology : CVI·Ellen E HigginsonSharon M Tennant

❮ Previous
Next ❯

Citations

Nov 27, 2019·Pathogens·Julia A Hotinger, Aaron E May

❮ Previous
Next ❯

Related Concepts

Related Feeds

B cell Differentiation

Depending on the signal received through the B cell receptor and other receptors, B cells differentiate into follicular or marginal zone B cells. Here is the latest research pertaining to this differentiation process.